PRK and LASIK reduces retinal image quality

Article

Performing photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) reduces the retinal image quality in myopic patients.

Performing photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) reduces the retinal image quality in myopic patients, declared a paper in the Journal of Cataract and Refractive Surgery.

The comparative case series, headed by Dr Meritxell Vilaseca, Universitat Politècnica de Catalunya, Terrassa, Barcelona Institute of Ocular Microsurgery, Barcelona, Spain, assessed 34 myopic eyes that underwent PRK and 55 myopic eyes that underwent LASIK.

Preoperatively and 3 months after PRK or LASIK optical quality was assessed with a clinical double-pass system. The team calculated the modulation transfer function (MTF), retinal image quality parameters (MTF cut-off frequency, Strehl ratio), and intraocular scattering [objective scatter index (OSI)].

PRK and LASIK demonstrated a statistically significant reduction on retinal image quality. However, there were no differences in reduction between the two techniques.

In the PRK group the MTF decreased by a factor of 1.50 and in the LASIK group it decreased by 1.32. The Strehl ratio was decreased by 1.10 and 1.07 for the PRK and LASIK group, respectively.

PRK and LASIK caused an increase in the objective scatter index by factors of 1.48 and 1.57, respectively. The preoperative refraction and the OSI were strongly linked.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.